Letter to the Editor

Endothelial Nitric Oxide Synthase 4a/B Polymorphism and Its Interaction with Enos G894T Variants in Type 2 Diabetic Patients: Modifying the Risk of Diabetic Nephropathy

1. Dellamea BS, Leitao CB, Friedman R, Canani LH (2014). Nitric oxide system and diabetic nephropathy. Diabetol Metab Syndr,6(1):17.
2. Lacchini R, Silva PS, Tanus-Santos JE (2010). A pharmacogenetics-based approach to reduce cardiovascular mortality with the prophylactic use of statins. Basic Clin Pharmacol Toxicol, 106(5):357-61.
3. Yahya MJ, Ismail PB, Nordin NB, et al (2019). CNDP1, NOS3, and MnSOD Polymorphisms as Risk Factors for Diabetic Nephropathy among Type 2 Diabetic Patients in Malaysia. J Nutr Metab, 2019:8736215.
4. Zhang Y, Xiao HQ, Zeng XT, Zuo HX, Xu YC (2015). Associations between endothelial nitric oxide synthase polymorphisms and risk of diabetic nephropathy: an updated meta-analysis. Renal Failure, 37(10):312-26.
5. Ahluwalia TS, Ahuja M, Rai TS, et al (2008). Endothelial nitric oxide synthase gene haplotypes and diabetic nephropathy among Asian Indians. Mol Cell Biochem,314(1-2):9-17.
Files
IssueVol 51 No 1 (2022) QRcode
SectionLetter to the Editor
DOI https://doi.org/10.18502/ijph.v51i1.8318

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Mohammadi M, Yaghooti H, Adibmanesh A, Mohammadtaghvaie N, Karimi Akhormeh A, Eslami M. Endothelial Nitric Oxide Synthase 4a/B Polymorphism and Its Interaction with Enos G894T Variants in Type 2 Diabetic Patients: Modifying the Risk of Diabetic Nephropathy. Iran J Public Health. 2022;51(1):219-220.